Homology modeling and virtual screening of inhibitors against TEM- and SHV-type-resistant mutants: A multilayer filtering approach

Biotechnology and Applied Biochemistry
Mohammad H BaigAsad U Khan

Abstract

TEM and SHV are class-A-type β-lactamases commonly found in Escherichia coli and Klebsiella pneumoniae. Previous studies reported S130G and K234R mutations in SHVs to be 41- and 10-fold more resistant toward clavulanic acid than SHV-1, respectively, whereas TEM S130G and R244S also showed the same level of resistance. These selected mutants confer higher level of resistance against clavulanic acid. They also show little susceptibility against other commercially available β-lactamase inhibitors. In this study, we have used docking-based virtual screening approach in order to screen potential inhibitors against some of the major resistant mutants of SHV and TEM types β-lactamase. Two different inhibitor-resistant mutants from SHV and TEM were selected. Moreover, we have retained the active site water molecules within each enzyme. Active site water molecules were placed within modeled structure of the mutant whose structure was unavailable with protein databank. The novelty of this work lies in the use of multilayer virtual screening approach for the prediction of best and accurate results. We are reporting five inhibitors on the basis of their efficacy against all the selected resistant mutants. These inhibitors were selected on ...Continue Reading

References

Nov 1, 1992·Acta Crystallographica. Section A, Foundations of Crystallography·D E Tronrud
Jan 1, 1988·Clinical Microbiology Reviews·K Bush
Feb 1, 1995·Protein Engineering·A C WallaceJ M Thornton
Jul 1, 1994·Intensive Care Medicine·S L Gorbach
Nov 1, 1995·Proteins·A SaliM Karplus
Apr 18, 1998·The Biochemical Journal·A MatagneJ M Frère
Aug 13, 1998·The Journal of Antimicrobial Chemotherapy·A F Goddard
Dec 11, 1999·Nucleic Acids Research·H M BermanP E Bourne
Aug 29, 2002·Journal of Computer-aided Molecular Design·Renxiao WangShaomeng Wang
Nov 3, 2004·Nature Reviews. Drug Discovery·Douglas B KitchenJürgen Bajorath
Dec 17, 2004·Nature·Brian K Shoichet
Jan 26, 2005·Journal of Chemical Information and Modeling·John J Irwin, Brian K Shoichet
Jun 17, 2005·Chemical Communications : Chem Comm·Gautam R Desiraju
Jan 24, 2007·Physical Chemistry Chemical Physics : PCCP·Zheng Li, Themis Lazaridis
Dec 25, 2007·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·R CantónE Gomez G de la Pedrosa
Jan 16, 2008·Antimicrobial Agents and Chemotherapy·Fabian Bös, Jürgen Pleiss
Mar 5, 2008·Antimicrobial Agents and Chemotherapy·Nuno MendonçaRichard Bonnet
May 13, 2008·Drug Discovery Today·Sten Ohlson
Oct 29, 2008·The Journal of Biological Chemistry·Priyaranjan PattanaikRobert A Bonomo
May 13, 2009·Journal of Chemical Information and Modeling·Kirk E HevenerRichard E Lee
Sep 15, 2009·Bioorganic & Medicinal Chemistry Letters·Wenya WangWannian Zhang
Jan 13, 2010·Clinical Microbiology Reviews·Sarah M Drawz, Robert A Bonomo
Sep 16, 2010·Expert Opinion on Therapeutic Patents·Karen Bush, Mark J Macielag
Nov 15, 2011·Methods in Molecular Biology·Amy C Anderson
Feb 3, 2012·Journal of Medicinal Chemistry·Derek A NicholsYu Chen
Apr 4, 2013·Theoretical Biology & Medical Modelling·Abdelmonaem MessaoudiJeannette Ben Hamida
Apr 23, 2013·Journal of Biomolecular Structure & Dynamics·Mohd DanishuddinAsad U Khan
Dec 1, 2004·Drug Discovery Today. Technologies·Christopher A Lipinski

❮ Previous
Next ❯

Citations

Jan 30, 2018·Biotechnology and Applied Biochemistry·Rajender VadijaUma Vuruputuri

❮ Previous
Next ❯

Related Concepts

Related Feeds

Beta-lactamase Inhibitors (ASM)

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Beta-lactamase Inhibitors

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.